[Diabetic dyslipidemia: which target levels and treatment options exist for diabetics?].
作者信息
Broedl U C, Lehrke M, Parhofer K G
机构信息
Medizinische Klinik und Poliklinik II, Campus Grosshadern, München.
出版信息
MMW Fortschr Med. 2008 Jun 19;150(25):41-3.
PMID:18705054
Abstract
摘要
相似文献
1
[Diabetic dyslipidemia: which target levels and treatment options exist for diabetics?].
MMW Fortschr Med. 2008 Jun 19;150(25):41-3.
2
[Dyslipidemia in diabetes mellitus].
Ned Tijdschr Geneeskd. 2001 Apr 21;145(16):769-74.
3
Diabetic dyslipidemia: extending the target beyond LDL cholesterol.
Eur J Cardiovasc Prev Rehabil. 2010 May;17 Suppl 1:S20-4. doi: 10.1097/01.hjr.0000368195.09485.17.
4
[Lipid therapy in risk patients. Do we concentrate too much on LDL cholesterol?].
MMW Fortschr Med. 2005 Apr 7;147(14):14.
5
[Disorders of lipid metabolism in 3 patients with diabetes mellitus type 2].
Ned Tijdschr Geneeskd. 2001 Apr 21;145(16):761-5.
6
[Favorable effects of decreasing lipids in patients with diabetes mellitus].
Dtsch Med Wochenschr. 2006 Dec;131 Suppl 8:S252-4. doi: 10.1055/s-2006-956284.
7
Management of dyslipidemia.
J Med Liban. 2001 Sep-Oct;49(5):274-8.
8
[Hypolipidemic drugs and diabetes mellitus].
Vnitr Lek. 2009 Apr;55(4):357-62.
9
Lipid disorders in type 2 diabetes.
Nurs Clin North Am. 2001 Jun;36(2):291-302, vii.
10
The dyslipidemia of diabetes mellitus: giving triglycerides and high-density lipoprotein cholesterol a higher priority?
Endocrinol Metab Clin North Am. 2005 Mar;34(1):27-48. doi: 10.1016/j.ecl.2004.11.004.
Zotero 插件